3 Biotech Stocks You Should Know About

02:35pm, Wednesday, 17'th Jul 2024
In June, we profiled biotech exchange-traded fund (ETF) SPDR S&P Biotech ETF (XBI) amid a historically bullish month.
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced today that it awarded a total of $1.5 million to 28 organizations through its Fun
Exact Sciences is facing a barrage of headwinds. The company's financial results haven't been good of late.
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its second quarter 2
The personalized medicine market is experiencing significant growth, driven by advancements in genomic technologies and a shift towards more individualized healthcare. In 2024, the market is expected
We are almost halfway through 2024, and the stock market is putting on a masterclass performance. The S&P 500 is up 12% year-to-date after rising 23% last year.
Software businesses like MongDB were a drag on the market in May. Medical testing company Exact Sciences also took a sharp turn lower.
Exact Sciences (EXAS) reported earnings 30 days ago. What's next for the stock?
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Exact Sciences (EXAS) has numerous competitors, given the large market for colorectal cancer screening.
Exact Sciences' (EXAS) latest study research result shows commitment to innovation and strategies that expand access to effective cancer screening and diagnostic tools for patients.
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the follow
With the S&P 500 sitting just a few points below setting a new all-time high, the bull market that began in 2022 is still snorting. Although a correction or even a bear market will eventually happen,
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, will present 10 abstracts highlighting the breadth and depth of the co
ST. LOUIS--(BUSINESS WIRE)--The court dismissed Exact Sciences' ‘781 patent infringement claim against Geneoscopy.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE